Celularity(CELU)
$0.75+0.04 (+5.63%)
CELU
Celularity financials statements
$0.75
At close:+0.04 (+5.63%)
Want to see CELU full AI Analyst Report?
Celularity (CELU) Ratios
219 Followers
Celularity Ratios
CELU's free cash flow for Q2 2026 was $-1.11M. For the 2026 fiscal year, CELU's free cash flow was increased by $0.00 and operating cash flow was $-1.11M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Mar 25 | Dec 23 | Dec 22 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.15 | 0.38 | 0.29 | 0.54 | 2.25 |
| Quick Ratio | 0.15 | 0.28 | 0.21 | 0.45 | 1.89 |
| Cash Ratio | 0.08 | 0.01 | 0.00 | 0.22 | 1.42 |
| Solvency Ratio | -0.58 | -0.40 | -1.82 | 0.12 | -0.29 |
| Operating Cash Flow Ratio | -0.16 | -0.12 | -0.57 | -2.22 | -4.20 |
| Short-Term Operating Cash Flow Coverage | -0.95 | -1.01 | -0.99 | -3.67 | -36.09 |
| Net Current Asset Value | $ -133.07M | $ -103.28M | $ -83.14M | $ -168.66M | $ -255.61M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.38 | 0.52 | 0.45 | 0.16 | 0.08 |
| Debt-to-Equity Ratio | -1.07 | 7.79 | 1.60 | 0.33 | 0.31 |
| Debt-to-Capital Ratio | 14.41 | 0.89 | 0.61 | 0.25 | 0.24 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.80 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -2.82 | 15.01 | 3.51 | 2.02 | 4.17 |
| Debt Service Coverage Ratio | -3.74 | -3.46 | -4.35 | -3.69 | -14.16 |
| Interest Coverage Ratio | -9.08 | -6.12 | -63.78 | 0.00 | -34.39 |
| Debt to Market Cap | 0.49 | 0.93 | 0.89 | 0.21 | 0.01 |
| Interest Debt Per Share | 1.86 | 3.43 | 3.84 | 4.69 | 5.12 |
| Net Debt to EBITDA | -0.45 | -1.56 | -0.35 | -0.37 | 0.07 |
| Profitability Margins | |||||
| Gross Profit Margin | 24.39% | 72.36% | 29.66% | -9.40% | 54.76% |
| EBIT Margin | -320.00% | -95.22% | -848.75% | -824.85% | -454.31% |
| EBITDA Margin | -292.52% | -80.61% | -807.81% | -772.36% | -412.98% |
| Operating Profit Margin | -230.92% | -70.75% | -844.44% | -142.42% | -511.17% |
| Pretax Profit Margin | -345.44% | -106.77% | -862.00% | 79.03% | -469.17% |
| Net Profit Margin | -345.45% | -106.77% | -862.04% | 78.95% | -469.27% |
| Continuous Operations Profit Margin | -345.45% | -106.77% | -862.04% | 78.95% | -469.27% |
| Net Income Per EBT | 100.00% | 100.00% | 100.01% | 99.91% | 100.02% |
| EBT Per EBIT | 149.59% | 150.93% | 102.08% | -55.49% | 91.78% |
| Return on Assets (ROA) | -85.45% | -43.63% | -136.42% | 3.54% | -24.18% |
| Return on Equity (ROE) | 240.96% | -655.11% | -479.24% | 7.14% | -100.70% |
| Return on Capital Employed (ROCE) | -230.74% | -48.55% | -251.06% | -7.55% | -28.12% |
| Return on Invested Capital (ROIC) | -151.11% | -44.94% | -166.01% | -6.79% | -27.90% |
| Return on Tangible Assets | -99.45% | -49.87% | -156.36% | 8.85% | -59.72% |
| Earnings Yield | -322.78% | -127.14% | -446.14% | 7.86% | -29.16% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.71 | 4.00 | 1.88 | 2.58 | 4.08 |
| Payables Turnover | 0.76 | 0.64 | 1.13 | 3.38 | 1.04 |
| Inventory Turnover | 35.16 | 2.77 | 2.78 | 3.70 | 1.01 |
| Fixed Asset Turnover | 0.40 | 0.75 | 0.29 | 0.20 | 0.24 |
| Asset Turnover | 0.25 | 0.41 | 0.16 | 0.04 | 0.05 |
| Working Capital Turnover Ratio | -0.52 | -1.35 | -0.60 | 8.38 | 0.54 |
| Cash Conversion Cycle | -406.07 | -344.31 | 3.01 | 132.13 | 98.30 |
| Days of Sales Outstanding | 63.97 | 91.26 | 194.24 | 141.45 | 89.53 |
| Days of Inventory Outstanding | 10.38 | 131.72 | 131.11 | 98.52 | 361.07 |
| Days of Payables Outstanding | 480.42 | 567.29 | 322.34 | 107.84 | 352.30 |
| Operating Cycle | 74.35 | 222.98 | 325.35 | 239.97 | 450.59 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.52 | -0.29 | -2.17 | -9.85 | -16.42 |
| Free Cash Flow Per Share | -0.52 | -0.30 | -2.40 | -10.23 | -17.34 |
| Dividend Paid and CapEx Coverage Ratio | -2.25 | -39.76 | -9.56 | -26.33 | -17.75 |
| Capital Expenditure Coverage Ratio | 0.00 | -39.76 | -9.56 | -26.33 | -17.75 |
| Operating Cash Flow Coverage Ratio | -0.32 | -0.09 | -0.59 | -2.10 | -3.54 |
| Operating Cash Flow to Sales Ratio | -0.50 | -0.12 | -1.70 | -7.67 | -5.16 |
| Free Cash Flow Yield | -46.65% | -14.41% | -97.12% | -79.30% | -33.87% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.31 | -0.79 | -0.22 | 12.72 | -3.43 |
| Price-to-Sales (P/S) Ratio | 1.07 | 0.84 | 1.93 | 10.04 | 16.09 |
| Price-to-Book (P/B) Ratio | -0.75 | 5.15 | 1.07 | 0.91 | 3.45 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -2.14 | -6.94 | -1.03 | -1.26 | -2.95 |
| Price-to-Operating Cash Flow Ratio | -2.14 | -7.11 | -1.14 | -1.31 | -3.12 |
| Price-to-Earnings Growth (PEG) Ratio | -0.01 | 0.01 | 0.00 | -0.12 | 0.04 |
| Enterprise Value Multiple | -0.81 | -2.60 | -0.59 | -1.67 | -3.83 |
| Enterprise Value | 63.14M | 113.63M | 109.19M | 232.10M | 337.23M |
| EV to EBITDA | -0.81 | -2.60 | -0.59 | -1.67 | -3.83 |
| EV to Sales | 2.38 | 2.10 | 4.80 | 12.91 | 15.81 |
| EV to Free Cash Flow | -4.76 | -17.32 | -2.56 | -1.62 | -2.90 |
| EV to Operating Cash Flow | -4.76 | -17.75 | -2.82 | -1.68 | -3.06 |
| Tangible Book Value Per Share | -2.08 | -0.35 | 1.27 | -2.99 | -21.93 |
| Shareholders’ Equity Per Share | -1.49 | 0.40 | 2.30 | 14.22 | 14.83 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | 0.00 | -0.00 | 0.00 | -0.00 |
| Revenue Per Share | 1.04 | 2.48 | 1.28 | 1.28 | 3.18 |
| Net Income Per Share | -3.58 | -2.64 | -11.02 | 1.01 | -14.93 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.08 | 1.12 | 1.02 | -0.10 | 1.03 |
| Research & Development to Revenue | 0.57 | 0.32 | 1.34 | 4.36 | 4.14 |
| SG&A to Revenue | 1.93 | 1.08 | 2.22 | 3.66 | 0.00 |
| Stock-Based Compensation to Revenue | 0.39 | 0.21 | 0.66 | 0.88 | 1.88 |
| Income Quality | 0.14 | 0.11 | 0.20 | -9.72 | 1.10 |
Currency in USD
